Read our latest news, responses and comments
Unacceptable endoscopy waiting times put launch of new world-class screening programme at risk
HRH Duke of Cambridge hails our merger as a success
Our Chief Executive, Deborah Alsina MBE, met HRH the Duke of Cambridge at the Charity Commission’s Annual Public Meeting.
Cantel (UK) Ltd announce Bowel Cancer UK as charity partner
We’re delighted that Cantel (UK) Limited has announced us as their Charity of the Year 2017.
Bowel Cancer UK policy and campaigns team shortlisted for Charity Times award
Our policy & campaigns team is shortlisted as a finalist for Campaigning Team of the Year in the Charity Times Awards 2017 – again!
First research grant round open with plans to invest up to half a million pounds
We've opened our first round of grant applications as part of our commitment to support research with the greatest benefits for those at risk and affected by the disease
Our chief executive shortlisted for prestigious award
Our chief executive Deborah Alsina MBE is shortlisted as a finalist for Charity Chief Executive of the Year in the Third Sector Excellence Awards 2017
NICE recommends FIT for people at low risk of bowel cancer
NICE has recommended that the Faecal Immunochemical Test (FIT) is used in primary care in England to guide GP referral for those at low risk of bowel cancer.
Thank you Edwards & Co for your £60,000 donation
Corporate partners Edwards & Co have donated over £60,000 for the charity over two and half years.
Bowel cancer diagnosis can be delayed due to existing illness
A new study reveals that additional serious long-term health conditions can push a bowel cancer diagnosis back by up to twenty six days.